Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04554693
Other study ID # 200544
Secondary ID
Status Recruiting
Phase Phase 4
First received
Last updated
Start date October 19, 2020
Est. completion date September 2027

Study information

Verified date October 2023
Source University of Louisville
Contact Amira Quevedo, MD
Phone 5025884400
Email amira.quevedo@uoflhealth.org
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to determine a difference in participant reported pain after endometriosis surgery in participants given oral metronidazole versus placebo.


Description:

The study is a prospective, randomized, placebo-controlled trial. Women scheduled for endometriosis surgery between 18-50 years of age will be invited to participate in the study. Participants with surgically staged endometriosis will be randomized to the metronidazole plus routine postoperative care arm or the placebo plus routine postoperative care arm. Participants will take study or placebo drug for a total of 14 days. Participants will complete surveys at baseline and postoperatively at 6 weeks, 6 months, 1 year, 2 years, 3 years, 4 years, and 5 years reporting intensity of endometriosis associated pain on a visual analog scale, pregnancy outcomes, quality of life, and sexual health.


Recruitment information / eligibility

Status Recruiting
Enrollment 90
Est. completion date September 2027
Est. primary completion date September 2027
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years to 50 Years
Eligibility Inclusion Criteria: - Able to give informed consent - Women aged 18-50 years old - Scheduled to undergo excision of endometriosis - Able to read and write in English and or Spanish - Pain score > 2 on a 10 point visual analogue scale at baseline - Negative screening by CAGE questionnaire Exclusion Criteria: - Refusal to surgery - Contraindication to surgery - Known allergy to metronidazole - Known allergy to any component in gelatin placebo capsules - Scheduled hysterectomy - Endometriosis excision surgery within the last 3 months - Elevated serum creatinine - Abnormal liver function test greater than 2 times the normal - Current pregnancy - Breastfeeding - Use of Disulfiram within the last 2 weeks - History of Cockayne syndrome - Inability to abstain from alcohol during the use of study drug

Study Design


Intervention

Drug:
Metronidazole Oral
250 mg oral three times a day for 14 days
Placebo
Halal and Kosher certified gelatin placebo capsules oral three times a day for 14 days

Locations

Country Name City State
United States University of Louisville Hospital Louisville Kentucky

Sponsors (1)

Lead Sponsor Collaborator
University of Louisville

Country where clinical trial is conducted

United States, 

References & Publications (14)

Abbott J, Hawe J, Hunter D, Holmes M, Finn P, Garry R. Laparoscopic excision of endometriosis: a randomized, placebo-controlled trial. Fertil Steril. 2004 Oct;82(4):878-84. doi: 10.1016/j.fertnstert.2004.03.046. — View Citation

Burney RO, Giudice LC. Pathogenesis and pathophysiology of endometriosis. Fertil Steril. 2012 Sep;98(3):511-9. doi: 10.1016/j.fertnstert.2012.06.029. Epub 2012 Jul 20. — View Citation

Chadchan SB, Cheng M, Parnell LA, Yin Y, Schriefer A, Mysorekar IU, Kommagani R. Antibiotic therapy with metronidazole reduces endometriosis disease progression in mice: a potential role for gut microbiota. Hum Reprod. 2019 Jun 4;34(6):1106-1116. doi: 10.1093/humrep/dez041. — View Citation

Glick LR, Sossenheimer PH, Ollech JE, Cohen RD, Hyman NH, Hurst RD, Rubin DT. Low-Dose Metronidazole is Associated With a Decreased Rate of Endoscopic Recurrence of Crohn's Disease After Ileal Resection: A Retrospective Cohort Study. J Crohns Colitis. 2019 Sep 19;13(9):1158-1162. doi: 10.1093/ecco-jcc/jjz047. — View Citation

Guo R, Chen LH, Xing C, Liu T. Pain regulation by gut microbiota: molecular mechanisms and therapeutic potential. Br J Anaesth. 2019 Nov;123(5):637-654. doi: 10.1016/j.bja.2019.07.026. Epub 2019 Sep 21. — View Citation

Leonardi M, Hicks C, El-Assaad F, El-Omar E, Condous G. Endometriosis and the microbiome: a systematic review. BJOG. 2020 Jan;127(2):239-249. doi: 10.1111/1471-0528.15916. Epub 2019 Sep 19. — View Citation

Mert I, Walther-Antonio M, Mariani A. Case for a role of the microbiome in gynecologic cancers: Clinician's perspective. J Obstet Gynaecol Res. 2018 Sep;44(9):1693-1704. doi: 10.1111/jog.13701. Epub 2018 Aug 2. — View Citation

Moloney RD, Johnson AC, O'Mahony SM, Dinan TG, Greenwood-Van Meerveld B, Cryan JF. Stress and the Microbiota-Gut-Brain Axis in Visceral Pain: Relevance to Irritable Bowel Syndrome. CNS Neurosci Ther. 2016 Feb;22(2):102-17. doi: 10.1111/cns.12490. Epub 2015 Dec 10. — View Citation

Nogueira F, Sharghi S, Kuchler K, Lion T. Pathogenetic Impact of Bacterial-Fungal Interactions. Microorganisms. 2019 Oct 16;7(10):459. doi: 10.3390/microorganisms7100459. — View Citation

Practice bulletin no. 114: management of endometriosis. Obstet Gynecol. 2010 Jul;116(1):223-236. doi: 10.1097/AOG.0b013e3181e8b073. No abstract available. — View Citation

Quaranta G, Sanguinetti M, Masucci L. Fecal Microbiota Transplantation: A Potential Tool for Treatment of Human Female Reproductive Tract Diseases. Front Immunol. 2019 Nov 26;10:2653. doi: 10.3389/fimmu.2019.02653. eCollection 2019. — View Citation

Simoens S, Hummelshoj L, D'Hooghe T. Endometriosis: cost estimates and methodological perspective. Hum Reprod Update. 2007 Jul-Aug;13(4):395-404. doi: 10.1093/humupd/dmm010. — View Citation

Sutton CJ, Ewen SP, Whitelaw N, Haines P. Prospective, randomized, double-blind, controlled trial of laser laparoscopy in the treatment of pelvic pain associated with minimal, mild, and moderate endometriosis. Fertil Steril. 1994 Oct;62(4):696-700. doi: 10.1016/s0015-0282(16)56990-8. — View Citation

Working group of ESGE, ESHRE and WES; Saridogan E, Becker CM, Feki A, Grimbizis GF, Hummelshoj L, Keckstein J, Nisolle M, Tanos V, Ulrich UA, Vermeulen N, De Wilde RL. Recommendations for the Surgical Treatment of Endometriosis. Part 1: Ovarian Endometrioma. Hum Reprod Open. 2017 Dec 19;2017(4):hox016. doi: 10.1093/hropen/hox016. eCollection 2017. — View Citation

* Note: There are 14 references in allClick here to view all references

Outcome

Type Measure Description Time frame Safety issue
Other Fertility Number of pregnancies and miscarriages postoperatively will be compared 6 months postoperatively
Other Fertility Number of pregnancies and miscarriages postoperatively will be compared 1 year postoperatively
Other Fertility Number of pregnancies and miscarriages postoperatively will be compared 5 years postoperatively
Primary Self-reported pain persistence The outcome of binary, subject pain persistence, assessed as yes or no, will be compared between groups using the Fisher exact test. 6 weeks postoperatively.
Secondary Quality of life scores Endometriosis Health Profile-5 on scale of 1-100 with higher scores meaning worse outcome 1 year postoperatively.
Secondary Quality of life scores Endometriosis Health Profile-5 on scale of 1-100 with higher scores meaning worse outcome 6 months postoperatively.
Secondary Quality of life scores Endometriosis Health Profile-5 on scale of 1-100 with higher scores meaning worse outcome 6 weeks postoperatively.
Secondary Quality of life scores Endometriosis Health Profile-5 on scale of 1-100 with higher scores meaning worse outcome 5 years postoperatively.
Secondary Sexual health Female sexual function index on a scale of 0-36 with higher scores meaning higher sexual dysfunction 6 weeks postoperatively.
Secondary Sexual health Female sexual function index on a scale of 0-36 with higher scores meaning higher sexual dysfunction 6 months postoperatively.
Secondary Sexual health Female sexual function index on a scale of 0-36 with higher scores meaning higher sexual dysfunction 1 year postoperatively.
Secondary Sexual health Female sexual function index on a scale of 0-36 with higher scores meaning higher sexual dysfunction 5 year postoperatively.
Secondary Self-reported pain persistence The outcome of binary, subject pain persistence, assessed as yes or no, will be compared between groups using the Fisher exact test. 1 year postoperatively.
Secondary Self-reported pain persistence The outcome of binary, subject pain persistence, assessed as yes or no, will be compared between groups using the Fisher exact test. 6 months postoperatively.
See also
  Status Clinical Trial Phase
Completed NCT01931670 - A Global Phase 3 Study to Evaluate the Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain Phase 3
Recruiting NCT05648669 - A Study to Evaluate Safety and Efficacy of Elagolix in Patients With Moderate to Severe Endometriosis-Associated Pain Phase 3
Completed NCT04081532 - The Effectiveness of Laparoscopic Treatment of Superficial Endometriosis for Managing Chronic Pelvic Pain N/A
Recruiting NCT06101303 - Endometriosis Pain
Completed NCT04665414 - Diagnosis of Adenomyosis Using Ultrasound, Elastography and MRI
Completed NCT03690765 - Study of Real Clinical Practice to Evaluate the Effects of Oral Dydrogesterone for Treatment of Confirmed Endometriosis
Recruiting NCT05153512 - ADOlescent DysmenoRrhea Endometriosis Assessment Magnetic Resonance Imaging (Adodream)
Active, not recruiting NCT04171297 - Ultrasound Evaluation of the Pelvis in Women With Suspected Endometriosis Scheduled for Laparoscopic Surgery
Recruiting NCT04172272 - The Influence of TAP Block in the Control of Postoperative Pain After Laparotomy for Gynecological Procedures N/A
Completed NCT04565470 - Strategies of Self-management of Endometriosis Symptoms
Completed NCT03613298 - Treatment by HIFU With Focal One® of Posterior Deep Infiltrating Endometriosis Lesions With Intestinal Involvement. N/A
Withdrawn NCT05568940 - Evaluating Tibolone Add-back in Patients With Endometriosis and Fibroids
Not yet recruiting NCT03464799 - Does Immunotherapy Have a Role in the Management of Endometriosis?
Active, not recruiting NCT03002870 - Characteristics of Patient Population With Endometriosis N/A
Withdrawn NCT03272360 - Endometriosis Biomarker Discovery Study N/A
Completed NCT02973854 - Activation of the Sphingosine-1-phosphate (S1P) to S1P1 Receptor Subtype (S1PR1) Axis in Patients With Endometriosis: Identification of Potential Relevant Biomarkers to Diagnose and Treat
Recruiting NCT02481739 - Laparoscopic Surgical Management of Endometriosis on Fertility N/A
Active, not recruiting NCT02754648 - Three Different Laparoscopic Approaches for Ovarian Endometrioma and the Effect on Ovarian Reserve N/A
Completed NCT06106932 - GnRH-a on Angiogenesis of Endometriosis N/A
Completed NCT02387931 - Supplementation in Adolescent Girls With Endometriosis Phase 4